MedPath

Survey Experiment to Estimate Level of Mental Illness Stigma Based on Condition and Gender

Not Applicable
Completed
Conditions
Stigma, Social
Mental Illness
Interventions
Other: Survey questionnaire
Registration Number
NCT06279962
Lead Sponsor
Yale University
Brief Summary

This study aims to measure levels of mental illness stigma based on condition and gender of the participants and individual portrayed with mental illness.

Detailed Description

This study aims to measure levels of mental illness stigma based on condition and gender of the participants and individual portrayed with mental illness. This study utilizes eight vignettes portraying different mental illnesses and genders to measure the levels of mental illness stigma in the general community in rural Uganda.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
379
Inclusion Criteria
  • All adults who consider Buyende District their primary residence and who are capable of providing consent
Exclusion Criteria
  • Minors younger than 18 years of age
  • Persons who do not consider Buyende District their primary place of residence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental: V2: Man with Major Depressive DisorderSurvey questionnaireDepicting a young man with symptomatic major depressive disorder
Experimental: V3: Man with Generalized Anxiety DisorderSurvey questionnaireDepicting a young man with symptomatic generalized anxiety disorder
Experimental: V6: Man with SchizophreniaSurvey questionnaireDepicting a young man with symptomatic schizophrenia
Experimental: V8: Man with Alcohol Use DisorderSurvey questionnaireDepicting a young man with symptomatic alcohol use disorder
Experimental: V5: Woman with SchizophreniaSurvey questionnaireDepicting a young woman with symptomatic schizophrenia
Experimental: V4: Woman with Generalized Anxiety DisorderSurvey questionnaireDepicting a young woman with symptomatic generalized anxiety disorder
Experimental: V1: Woman with Major Depressive DisorderSurvey questionnaireDepicting a young woman with symptomatic major depressive disorder
Experimental: V7: Woman with Alcohol Use DisorderSurvey questionnaireDepicting a young woman with symptomatic alcohol use disorder
Primary Outcome Measures
NameTimeMethod
Level of acceptance for the individual depicted in the vignette as measured by PERSONAL ACCEPTANCE SCALEStudy period. For each interview, approximately 60 minutes.

The PAS is a 9-item questionnaire targeted to public stigma, the "negative attitudes, beliefs, and behaviors held within a community" against individuals with mental illness. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. The total number of points was divided by the number of questions (nine) and multiplied by ten to generate numbers between zero and ten for comparison purposes to the Broad Acceptance Scale. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.

Level of acceptance for the individual depicted in the vignette as measured by BROAD ACCEPTANCE SCALEStudy period. For each interview, approximately 60 minutes.

The BAS is a 9-item questionnaire targeted to structural stigma, the "societal-level conditions, cultural norms, and institutional practices that constrain the opportunities, resources, and wellbeing" for individuals with mental illness. Each yes adds one point to the scale, and five questions from each scale were reverse-scored to match the direction of the scale. There were ten questions, therefore it generated a score between zero and ten. Higher scores indicated more acceptance and less stigma towards mental illness, while lower scores indicated less acceptance and more stigma towards mental illness.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Empowerment to Heal - Uganda

🇺🇬

Iganga, Uganda

© Copyright 2025. All Rights Reserved by MedPath